AOAkif Muhtar Ozturk

Akif Muhtar Ozturk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akif Muhtar Ozturk has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Abdullah Yalcin Tabak

    Ankara Numune Research and Training Hospital, 5th Orthopaedics and Traumatology Clinic, Ankara, Turkey

    2 shared publications
  • Cem Nuri Aktekin

    Ankara Numune Research and Training Hospital, 5th Orthopaedics and Traumatology Clinic, Ankara, Turkey

    2 shared publications
  • Feza Korkusuz

    Medical Center, Middle East Technical University, Ankara, Turkey

    2 shared publications
  • Murat Altay

    Ankara Numune Research and Training Hospital, 5th Orthopaedics and Traumatology Clinic, Ankara, Turkey

    2 shared publications
  • Agnes Tan

    Department of Hand Surgery, Singapore General Hospital, Singapore

    1 shared publication
  • Akin Yilmaz

    Department of Medical Biology, Faculty of Medicine, Hitit University, Çorum, Turkey

    1 shared publication

Latest Publications

  • Bupivacaine and levobupivacaine induce apoptosis in rat chondrocyte cell cultures at ultra-low doses

    by Irfan Gungor, Akin Yilmaz, Akif Muhtar Ozturk, Mehmet Ali Ergun, Sevda Menevse, Kadir Kaya

    Osteoarthritis (OA) is characterized by chondrocyte apoptosis and necrosis which play a key role during the progression of OA. Intra-articular administration of bupivacaine is a practical and effective way of postoperative pain control following various joint surgeries. 0.25 % bupivacaine showed to be safe in terms of chondrocyte toxicity. Around 200 nM of bupivacaine was shown to be effective for peripheral nerve block. This study aims to observe the possible cytotoxic effects of bupivacaine and its enantiomer levobupivacaine on chondrocyte cell culture at 7.69, 76.9, and 384.5 μM or at 0.0125, 0.0025, and 0.00025 % concentrations, respectively. Chondrocytes were isolated from rat articular cartilage after incubating with collagenase in RPMI-1640 medium. Cells were treated with bupivacaine and levobupivacaine at 7.69, 76.9, and 384.5 μM concentrations for 6, 24, and 48 h. Treated chondrocytes were stained with acridine orange and ethidium bromide and examined under a fluorescence microscope at a 490 nm excitation wavelength for apoptotic changes. Study results suggest that both bupivacaine and levobupivacaine have dose-dependent chondrocyte toxicity, and this is significantly lesser at 7.69 μM dose. There was no significant difference in terms of chondrocyte apoptosis, (p > 0.05). Clinicians should be skeptic for the serious long-term side effects of bupivacaine and its analogs, even at ultra-low doses.


  • Synovial cell culture and tissue engineering of a tendon synovial cell biomembrane

    by Akif Muhtar Ozturk, Andrew Yam, Song In Chin, Tan Soo Heong, Fatma Helvacioglu, Agnes Tan

    Restrictive adhesions are a common complication of tendon injury and repair in the hand, resulting in severe dysfunction. Creating a barrier between the repair sites and surrounding tissue layers may prevent adhesions. We present the first stage in the process of developing a synovial biomembrane for this purpose. Synovial cells harvested from the Achilles tendon sheath and the knee joint of a Wistar albino rat were cultured for 2 weeks in culture medium, and then impregnated into a collagen type 1 matrix for another 2 weeks. Cells originating from both tendon and synovium demonstrated cell growth and layer formation on the surfaces of the matrix 2 weeks after impregnation. Alcian blue staining using Scott's method demonstrated the presence of acidic mucopolysaccharide, indicating hyaluronic acid (HA) production. This provides indirect evidence of functioning synovial cells on the membrane. It is possible to culture synovial cells and engineer a synoviocyte–collagen membrane that synthesizes endogenous HA. Application of this biomembrane to tendon repair sites may help to prevent adhesions after tendon repairs. Evaluation of this method on in vivo models is required. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2008


  • A different perspective for radiological evaluation of experimental osteomyelitis

    by Cem Nuri Aktekin, Akif Muhtar Ozturk, Abdullah Yalcin Tabak, Murat Altay, Feza Korkusuz

    Introduction Radiological scoring systems used in experimental osteomyelitis combine several factors into a single score. Because response of bone tissue to infection is a dynamic process, such systems have limited ability to differentiate between treatment groups. The analyzing of radiological criteria separately at different stages of the disease may be superior to a general score. Methods and methods Osteomyelitis was induced with Staphylococcus aureus in the left tibiae of 72 adult Wistar albino rats. The rats were assigned to one of six different treatment groups. Their radiographs were graded (1) by the use of previously published general scoring systems and (2) by the evaluation of periosteal reaction, bone deformation, diaphyseal widening, osteolysis, soft tissue swelling, bone mineral content (BMC) and bone mineral density (BMD), separately. The assessments were performed 3 weeks after induction as well as 3 weeks and 6 weeks after treatment. Results Periosteal reaction and diaphyseal widening demonstrated significant differences within 3 weeks of treatment, contrary to the general scores. After 6 weeks of treatment, individual criteria, including diaphyseal widening, osteolysis and BMC but only one of the general grading scores, were able to differentiate between treatment groups. Conclusions For differentiation of treatments in experimental osteomyelitis individual assessment of radiological criteria is superior to previously published general scoring systems.


  • Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis

    by Akif Muhtar Ozturk, Abdullah Yalcin Tabak, Cem Nuri Aktekin, Murat Altay, Esra Erdemli, Sercin Karahuseyinoglu, Feza Korkusuz

    Bisphosphonates are systemic drugs. There is limited knowledge about their effects when applied locally and in osteomyelitis treatment. A prospective longitudinal randomised controlled study was designed in rat tibia to test the efficacy of local or systemically administered bisphosphonates for controlling the osteolytic reactions and possible effects on local infection control. Tibial osteomyelitis was induced in 72 Wistar albino rats with Staphylococcus aureus ATCC 25923 strain. Débridement was performed on all rats in all groups. No other treatment was given to the control group. Treatment groups received “plain bone grafts”, “vancomycin-loaded bone grafts”, “vancomycin-loaded bone grafts+systemic alendronate”, “alendronate-impregnated bone grafts” and “vancomycin+alendronate-impregnated grafts”. Study results were evaluated by swab cultures, radiology, quantitative computed tomography, dual-energy X-ray absorptiometry (DEXA) and histopathology. S. aureus was eradicated in groups II and IV by the sixth week. Diaphyseal widening, bone deformation, diaphyseal widening and osteolysis scores were significantly lower (p < 0.05), and bone mineral content, density measurements and DEXA scores were significantly higher (p = 0.001) with alendronate administration. Histology revealed marked osteoblastic activity. Local alendronate interfered with local infection control. Even though local alendronate at the given dose has stronger effects, the possible effects on the local inflammatory process needs to be clarified.